×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
LXEO – lexeo therapeutics, inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
LXEO
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
11/18
06:26 am
lxeo
How decentralisation can fill the gaps in Alzheimer's research [Yahoo! Finance]
High
Report
How decentralisation can fill the gaps in Alzheimer's research [Yahoo! Finance]
11/14
08:15 am
lxeo
Lexeo Therapeutics, Inc. (NASDAQ: LXEO) had its price target raised by analysts at HC Wainwright from $21.00 to $23.00. They now have a "buy" rating on the stock.
Low
Report
Lexeo Therapeutics, Inc. (NASDAQ: LXEO) had its price target raised by analysts at HC Wainwright from $21.00 to $23.00. They now have a "buy" rating on the stock.
11/13
05:47 pm
lxeo
Lexeo Therapeutics, Inc. (NASDAQ: LXEO) had its price target raised by analysts at Chardan Capital from $23.00 to $25.00. They now have a "buy" rating on the stock.
Low
Report
Lexeo Therapeutics, Inc. (NASDAQ: LXEO) had its price target raised by analysts at Chardan Capital from $23.00 to $25.00. They now have a "buy" rating on the stock.
11/13
01:46 pm
lxeo
Lexeo Therapeutics, Inc. (NASDAQ: LXEO) had its price target lowered by analysts at Leerink Partners from $20.00 to $19.00. They now have an "outperform" rating on the stock.
Medium
Report
Lexeo Therapeutics, Inc. (NASDAQ: LXEO) had its price target lowered by analysts at Leerink Partners from $20.00 to $19.00. They now have an "outperform" rating on the stock.
11/13
11:12 am
lxeo
Lexeo Therapeutics GAAP EPS of -$0.89 misses by $0.24 [Seeking Alpha]
High
Report
Lexeo Therapeutics GAAP EPS of -$0.89 misses by $0.24 [Seeking Alpha]
11/13
07:30 am
lxeo
Lexeo Therapeutics Provides Update on Cardiac Portfolio and Reports Third Quarter 2024 Financial Results
Low
Report
Lexeo Therapeutics Provides Update on Cardiac Portfolio and Reports Third Quarter 2024 Financial Results
10/31
08:35 am
lxeo
Lexeo Therapeutics, Inc. (NASDAQ: LXEO) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $21.00 price target on the stock.
Medium
Report
Lexeo Therapeutics, Inc. (NASDAQ: LXEO) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $21.00 price target on the stock.
10/30
06:14 am
lxeo
Lexeo Therapeutics Announces Positive Interim Data for LX1001, First-Ever Gene Therapy to Impact the Underlying Genetic Cause of APOE4-Associated Alzheimer’s Disease, at the Clinical Trials on Alzheimer’s Disease (CTAD) Conference
High
Report
Lexeo Therapeutics Announces Positive Interim Data for LX1001, First-Ever Gene Therapy to Impact the Underlying Genetic Cause of APOE4-Associated Alzheimer’s Disease, at the Clinical Trials on Alzheimer’s Disease (CTAD) Conference
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
11/14
05:50 pm
lxeo
Form SC 13G/A Lexeo Therapeutics, Inc. Filed by: Lundbeckfond Invest A/S
High
Report
Form SC 13G/A Lexeo Therapeutics, Inc. Filed by: Lundbeckfond Invest A/S
11/14
04:46 pm
lxeo
Form SC 13G/A Lexeo Therapeutics, Inc. Filed by: Longitude Capital Partners IV, LLC
High
Report
Form SC 13G/A Lexeo Therapeutics, Inc. Filed by: Longitude Capital Partners IV, LLC
11/14
12:32 pm
lxeo
Form SC 13G/A Lexeo Therapeutics, Inc. Filed by: JANUS HENDERSON GROUP PLC
Low
Report
Form SC 13G/A Lexeo Therapeutics, Inc. Filed by: JANUS HENDERSON GROUP PLC
11/14
12:23 pm
lxeo
Form SC 13G/A Lexeo Therapeutics, Inc. Filed by: EVENTIDE ASSET MANAGEMENT, LLC
Low
Report
Form SC 13G/A Lexeo Therapeutics, Inc. Filed by: EVENTIDE ASSET MANAGEMENT, LLC
11/13
05:35 pm
lxeo
Form 4 Lexeo Therapeutics, Inc. For: Nov 11 Filed by: Tanguler Tolga
Low
Report
Form 4 Lexeo Therapeutics, Inc. For: Nov 11 Filed by: Tanguler Tolga
11/13
05:33 pm
lxeo
Form 4 Lexeo Therapeutics, Inc. For: Nov 11 Filed by: Townsend Richard Nolan
Low
Report
Form 4 Lexeo Therapeutics, Inc. For: Nov 11 Filed by: Townsend Richard Nolan
11/13
05:32 pm
lxeo
Form 3 Lexeo Therapeutics, Inc. For: Nov 11 Filed by: Tanguler Tolga
Low
Report
Form 3 Lexeo Therapeutics, Inc. For: Nov 11 Filed by: Tanguler Tolga
11/13
07:35 am
lxeo
Form 424B3 Lexeo Therapeutics, Inc.
Low
Report
Form 424B3 Lexeo Therapeutics, Inc.
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
TOP News Decliners
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: